Drug Shortage Report for RAN-ROPINIROLE

Last updated on 2020-10-28 History
Report ID 75900
Drug Identification Number 02314037
Brand name RAN-ROPINIROLE
Common or Proper name RAN-ROPINIROLE
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) ROPINIROLE
Strength(s) 0.25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N04BC
ATC description DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-02-08
Estimated end date 2020-10-23
Actual end date 2020-10-23
Shortage status Resolved
Updated date 2020-10-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2020-10-28 French Compare
v29 2020-10-28 English Compare
v28 2020-10-07 French Compare
v27 2020-10-07 English Compare
v26 2020-08-28 French Compare
v25 2020-08-28 English Compare
v24 2020-05-27 French Compare
v23 2020-05-27 English Compare
v22 2019-12-13 French Compare
v21 2019-12-13 English Compare
v20 2019-09-13 French Compare
v19 2019-09-13 English Compare
v18 2019-08-19 French Compare
v17 2019-08-19 English Compare
v16 2019-07-19 French Compare
v15 2019-07-19 English Compare
v14 2019-06-07 French Compare
v13 2019-06-07 English Compare
v12 2019-05-13 French Compare
v11 2019-05-13 English Compare

Showing 1 to 20 of 30